Portfolio company
CamGene
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops RNA-based therapeutics using lipid nanoparticle technology to treat hearing loss for patients with cellular dysfunction or undergoing cochlear implant surgery.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
CamGene Therapeutics
This biotechnology company develops RNA-based medicines and lipid nanoparticle delivery technologies to treat hearing loss for patients with cellular dysfunction or cochlear implants.
Sensorion
This company develops gene therapies and small molecule drugs to restore, treat and prevent inner ear disorders for patients with hearing loss.
Akouos
The company develops gene therapies to restore, improve and preserve hearing for individuals with disabling sensorineural hearing loss.
CureAge
This company develops curative gene therapies for patients with neurofibromatosis type 1 and other peripheral nerve diseases using lipid nanoparticle technology.
Decibel Therapeutics
This biotechnology company develops gene therapies to restore hearing and balance for patients with congenital hearing loss and related genetic disorders.
Shape Therapeutics
The company develops programmable RNA medicines and delivery systems for patients with genetic disorders and other hard-to-treat diseases.
Hone Bio
This company develops lipid nanoparticle targeting technology for pharmaceutical and biotechnology firms to enable precise drug delivery beyond the liver.
Capstan Therapeutics
Capstan Therapeutics develops in vivo RNA-based therapies for patients with autoimmune diseases and cancers using targeted lipid nanoparticle technology.
